Drug on the Market
In Global Business this week Peter Day hears from Dr. Andrea Pfeifer founder of a small biotech company in Switzerland looking for an effective treatment for Alzheimers disease.
Every 72 seconds a new patient is diagnosed with Alzheimer’s disease and it’s estimated by 2050 healthcare costs will be around $1 trillion, a big worry in a world with an ageing population. In this week’s Global Business Peter Day hears from Dr. Andrea Pfeifer of the Swiss biotech company, AC Immune and hears how this small company is making encouraging strides in it’s quest for effective treatments for Alzheimer’s Disease.
Last on
Broadcasts
- Tue 20 Jul 2010 08:05GMTΒι¶ΉΤΌΕΔ World Service Online
- Tue 20 Jul 2010 11:05GMTΒι¶ΉΤΌΕΔ World Service Online
- Tue 20 Jul 2010 19:05GMTΒι¶ΉΤΌΕΔ World Service Online
- Wed 21 Jul 2010 00:05GMTΒι¶ΉΤΌΕΔ World Service Online
- Sat 24 Jul 2010 22:05GMTΒι¶ΉΤΌΕΔ World Service Online
- Sun 25 Jul 2010 18:05GMTΒι¶ΉΤΌΕΔ World Service Online
Advice For Entrepreneurs
What is the one piece of advice successful global entrepreneurs would offer?
Download this programme
Subscribe to this programme or download individual episodes.